ABI-007, nanoparticle albumin-bound paclitaxel, enhances tumor radioresponse.

被引：0
|
作者：
Mason, Kathy A. [1 ]
Wiedenmann, Nicole [1 ]
Valdecanas, David [1 ]
Buchholz, Thomas [1 ]
Milas, Luka [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5439
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel
    Ibrahim, NK
    Desai, N
    Legha, S
    Soon-Shiong, P
    Theriault, RL
    Rivera, E
    Esmaeli, B
    Ring, SE
    Bedikian, A
    Hortobagyi, GN
    Ellerhorst, JA
    CLINICAL CANCER RESEARCH, 2002, 8 (05) : 1038 - 1044
  • [42] A phase I trial of ABI-007, nanoparticle paclitaxel, administered to patients with advanced non-hematologic malignancies.
    Nyman, DW
    Campbell, KJ
    Hersh, E
    Richardson, K
    Patrick, K
    Trieu, V
    Desai, N
    Von Hoff, DD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 133S - 133S
  • [43] Neoadjuvant chemotherapy with sequential weekly nanoparticle albumin-bound paclitaxel (ABI-007, Abraxane®) followed by 5-fluorouracil, epirubicin and cyclophosphamide (FEC) in locally advanced breast cancer (LABC):: A phase II trial of the NSABP foundation research programs (FRP).
    Robidoux, A.
    Buyse, M.
    Buzdar, A.
    Geyer, C. E.
    Pajon, E.
    DiNunno, L.
    Desai, A.
    Fehrenbacher, L.
    Kuerer, H.
    Liles, D.
    Paik, S.
    Mamounas, E.
    Wolmark, N.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S147 - S147
  • [44] Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL(R)-free formulation of paclitaxel
    Stinchcombe, Thomas E.
    NANOMEDICINE, 2007, 2 (04) : 415 - 423
  • [45] Toxic erythema with eccrine squamous syringometaplasia induced by nanoparticle albumin-bound paclitaxel
    Fujii, Mizue
    Takahashi, Ichiro
    Honma, Masaru
    Ishida-Yamamoto, Akemi
    JOURNAL OF DERMATOLOGY, 2015, 42 (11): : 1134 - 1135
  • [46] An NMR Protocol for In Vitro Paclitaxel Release from an Albumin-Bound Nanoparticle Formulation
    Min Sung Suh
    Sharadrao M. Patil
    Darby Kozak
    Eric Pang
    Stephanie Choi
    Xiaohui Jiang
    Jason D. Rodriguez
    David A. Keire
    Kang Chen
    AAPS PharmSciTech, 21
  • [47] SAFETY OF WEEKLY ADMINISTRATION OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL IN PATIENTS WITH BREAST CANCER
    Seki, H.
    Asanuma, F.
    Yamada, Y.
    Hirata, Y.
    Kaneda, M.
    Suzuki, K.
    Osaku, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E41 - E41
  • [48] Repetitive responses to nanoparticle albumin-bound paclitaxel and carboplatin in malignant pleural mesothelioma
    Kanai, Osamu
    Fujita, Kohei
    Nakatani, Koichi
    Mio, Tadashi
    RESPIROLOGY CASE REPORTS, 2016, 4 (01): : 28 - 31
  • [49] Efficacy and safety of concurrent chemoradiotherapy with carboplatin and nanoparticle albumin-bound paclitaxel.
    Kanai, Osamu
    Ito, Takanori
    Saito, Zentaro
    Imakita, Takuma
    Oi, Issei
    Yamamoto, Yuki
    Fujita, Kohei
    Tanizawa, Kiminobu
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [50] Comparison of Peripheral Neuropathy Induced by Standard and Nanoparticle Albumin-Bound Paclitaxel in Rats
    Yamashita, Yuji
    Egashira, Nobuaki
    Masuguchi, Ken
    Ushio, Soichiro
    Kawashiri, Takehiro
    Oishi, Ryozo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 117 (02) : 116 - 120
12345